The low priority accorded to health care in India has resulted in a vicious cycle of disease, death and destitution. Over 63 million Indians slip into poverty every year as high health care costs......
Biotechnology major Biocon has bagged the 2009 BioSingapore Asia Pacific Biotechnology Award for being the Best Listed Company. Biocon was selected on the basis of its significant market capital,......
Biocon Ltd ill seek Drug Controller General of India's approval for its novel monoclonal antibody indicated towards the treatment of head and neck cancer, Biomab EGFR."We will be submitting an......
Biocon CMD Kiran Mazumdar-Shaw has been named in the world's top 100 ‘effective and talented’ people by US-based 'Scientific American' magazine, which hailed her contribution in......
Amid the global meltdown and downsizing of staff by several firms, leading biotechnology firm Biocon on Thursday said it plans to hire around 200 more people in this fiscal. "We will continue to......
India's largest biotechnology firm Biocon could be developing potential 'blockbuster' drugs for treatment of cancer and diabetes, but the company's CMD Kiran Mazumdar-Shaw said it could take......